MoneyAM MoneyAM
 Home   Log In   Register   Our Services   My Account   Contact   Help 
 Stockwatch   Level 2   Portfolio   Charts   Research   Share Price   Awards   Indices   Market Scan   Company Zone   Traders' Room 
 Funds   Trades   Terminal   Alerts   Heatmaps   News   Stock Screener   Forward Diary   Forex Prices   Director Deals   Investors' Room 
 CFDs   Shares   SIPPs   ISAs   Forex   ETFs   Videos   Comparison Tables   Spread Betting   Broker Notes   Shares Magazine 
You are NOT currently logged in

 
Filter Criteria  
Epic: Keywords: 
From: Time:  (hh:mm) RNS:  MonAM: 
To: Time:  (hh:mm)
Please Note - Streaming News is only available to subscribers to the Active Level and above
 


IN BRIEF: High Court sanctions Mediclinic takeover by Remgro

ALN

Mediclinic International PLC - Stellenbosch-based private healthcare provider - Says High Court of Justice of England and Wales sanctions takeover by consortium led by Johannesburg investment firm Remgro Ltd. Deal values Mediclinic at around £3.7 billion. Consortium comprises MSC Mediterranean Shipping Co SA subsidiary SAS Shipping Agencies Services Sarl and Manta Bidco Ltd, a newly formed company owned by Remgro and SAS. Consortium in August 2022 announced agreement on terms of Bidco’s cash offer for all Mediclinic shares not already owned by Remgro subsidiaries. Scheme of arrangement was sanctioned by High Court following a hearing yesterday. The sanction will take effect tomorrow, one business day later than specified in Mediclinic’s timetable announced on Tuesday last week. Suspension of trading in Mediclinic shares in London is expected to take effect tomorrow, with cancellation effective next Tuesday morning. Shares also will be suspended in Johannesburg and Sydney, effective tomorrow, with cancellation effective June 7.

Mediclinic current London stock price: 500.50 pence, flat on Thursday

12-month change: up 34%

Mediclinic current Johannesburg stock price: R 118.10, up 0.2% on Thursday

12-month change: up 64%

Copyright 2023 Alliance News Ltd. All Rights Reserved.